BLSM
BlossomHill Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$22.01
+9.94%Leverage
- Debt / equity
- -0.15x
- Net debt / equity
- 0.61x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.36x
- Net debt / EBITDA
- 1.46x
Liquidity & coverage
- Current ratio
- 7.40x
- Quick ratio
- 7.40x
- Cash ratio
- 7.17x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $103.5M
Cash & dividend
- FCF / debt
- -2.08x
- Cash flow / debt
- -2.04x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026